Cited by 202MicroRNA in disease regulationGlioma Diagnosis and TreatmentExtracellular vesicles in disease

Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma

Open access
Wang, Qiong, Li, Pengcun, Li, Ailin, Jiang, Wei, Wang, Hong, Wang, Jinhuan, Xie, Keliang·2012·Journal of Experimental & Clinical Cancer Research

Abstract

OBJECTIVE: Glioblastoma multiforme (GBM) is a highly malignant brain tumor with a poor prognosis. MicroRNAs (miRNAs) are a class of small non-coding RNAs, approximately 21-25 nucleotides in length. Recently, some researchers have demonstrated that plasma miRNAs are sensitive and specific biomarkers of various cancers. The primary aim of the study is to investigate whether miRNAs present in the plasma of GBM patients can be used as diagnostic biomarkers and are associated with glioma classification and clinical treatment. MATERIALS AND METHODS: Plasma samples were attained by venipuncture from 50 patients and 10 healthy donors. Plasma levels of miRNAs were determined by real-time quantitative polymerase chain reaction. RESULTS: The plasma levels of miR-21, miR-128 and miR-342-3p were significantly altered in GBM patients compared to normal controls and could discriminate glioma from healthy controls with high specificity and sensitivity. However, these three miRNAs were not significantly changed in patients with other brain tumors such as meningioma or pituitary adenoma. Furthermore, the plasma levels of these three miRNAs in GBM patients treated by operation and chemo-radiation almost revived to normal levels. Finally, we also demonstrated that miR-128 and miR-342-3p were positively correlated with histopathological grades of glioma. CONCLUSIONS: These findings suggest that plasma specific miRNAs have potential use as novel biomarkers of glioma and may be useful in clinical management for glioma patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1756-9966-31-97

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Serum miR-21 expression levels were significantly higher in pre-operative glioma samples than in postoperative serum of grade 2 (p=0.0079), grade 3 (p=0.0079) and grade 4 (p=0.0096).

    “Moreover, the serum expression levels were also significantly higher in pre-operative glioma samples than in postoperative serum of grade 2 (p=0.0079 ), grade 3 (p=0.0079) and grade 4 (p=0.0096)which is consistent with previous findings [26,30] .”

    From miR-21 as a diagnostic and prognostic biomarker in glioma: tissue and serum expression analysis in a Pakistani cohort (2026) · cites this paper as [30]

    The Results section on treatment changes reports no significant difference in plasma miR-21 between pre- and postoperative GBM samples (P = 0.393), contrary to the claimed significant decrease. Its grade II–IV comparison concerns glioma samples versus healthy controls, not grade-specific pre- and postoperative serum comparisons. (LLM, conf=0.94)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • The increase in miR-21 levels may be linked to its role in angiogenesis and tumor proliferation, key features of grade 4 tumors.

    “This increase in miR-21 levels may be linked to its role in angiogenesis and tumor proliferation, key features of grade 4 tumors [29,30].”

    From miR-21 as a diagnostic and prognostic biomarker in glioma: tissue and serum expression analysis in a Pakistani cohort (2026) · cites this paper as [30]

    The Results section on histopathological grade (page not provided) reports elevated plasma miR-21 in grade IV glioblastoma compared with controls, supporting the reported increase. The Discussion (page not provided) describes miR-21 as anti-apoptotic, but does not link the increase to angiogenesis or tumor proliferation. The Results also say miR-21 expression was not associated with glioma grade, so the proposed grade-IV-specific explanation is not supported. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 25

  1. Fire A Xu S Montgomery MK Kostas SA Driver SE Mello CC Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 1998 391 806 811 10.1038/35888 9486653 · DOI · Paper page
  2. Bartel DP MicroRNAs: genomics, biogenesis, mechanism and function Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438 · DOI
  3. Ambros V The function of animal microRNAs Nature 2004 431 350 355 10.1038/nature02871 15372042 · DOI · Paper page
  4. Plasterk RH MicroRNAs in animal development Cell 2006 124 877 881 10.1016/j.cell.2006.02.030 16530032 · DOI
  5. Lu J Getz G Miska EA Alvarez-Saavedra E Lamb J Peck D Sweet-Cordero A Ebert BL Mak RH Ferrando AA Downing JR Jacks T Horvitz HR Golub TR MicroRNA expression profiles classify human cancers Nature 2005 435 834 838 10.1038/nature03702 15944708 · DOI
  6. Esquela-Kerscher A Slack FJ Oncomirs: MicroRNAs with a role in cancer Nat Rev Cancer 2006 6 255 269 16557279
  7. Calin GA Croce CM MicroRNA signatures in human cancers Nat Rev Cancer 2006 6 857 866 10.1038/nrc1997 17060945 · DOI
  8. Mitchell PS Parkin RK Kroh EM Fritz BR Wyman SK Pogosova-Agadjanyan EL Peterson A Noteboom J O’Briant KC Allen A Lin DW Urban N Drescher CW Knudsen BS Stirewalt DL Gentleman R Vessella RL Nelson PS Martin DB Tewari M Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci USA 2008 105 10513 10518 10.1073/pnas.0804549105 18663219 PMC2492472 · DOI · Paper page
  9. Baraniskin A Kuhnhenn J Schlegel U Maghnouj A Zöllner H Schmiegel W Hahn S Schroers R Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma Neuro Oncol 2012 14 29 33 10.1093/neuonc/nor169 21937590 PMC3245991 · DOI
  10. Roth P Wischhusen J Happold C Chandran PA Hofer S Eisele G Weller M Keller A A specific miRNA signature in the peripheral blood of glioblastoma patients J Neurochem 2011 118 449 457 10.1111/j.1471-4159.2011.07307.x 21561454 · DOI
  11. Conti A Aguennouz M La Torre D Tomasello C Cardali S Angileri FF Maio F Cama A Germanò A Vita G Tomasello F miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors J Neurooncol 2009 93 325 332 10.1007/s11060-009-9797-4 19159078 · DOI
  12. Chan JA Krichevsky AM Kosik KS MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells Cancer Res 2005 65 6029 6033 10.1158/0008-5472.CAN-05-0137 16024602 · DOI · Paper page
  13. Ciafrè SA Galardi S Mangiola A Ferracin M Liu CG Sabatino G Negrini M Maira G Croce CM Farace MG Extensive modulation of a set of microRNAs in primary glioblastoma Biochem Biophys Res Commun 2005 334 1351 1358 10.1016/j.bbrc.2005.07.030 16039986 · DOI · Paper page
  14. Xia H Qi Y Ng SS Chen X Chen S Fang M Li D Zhao Y Ge R Li G Chen Y He ML Kung HF Lai L Lin MC MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells Biochem Biophys Res Commun 2009 380 205 210 10.1016/j.bbrc.2008.12.169 19135980 · DOI
  15. Wang JF Yu ML Yu G Bian JJ Deng XM Wan XJ Zhu KM Serum miR-146a and miR-223 as potential new biomarkers for sepsis Biochem Biophys Res Commun 2010 394 184 188 10.1016/j.bbrc.2010.02.145 20188071 · DOI
  16. Cui JG Zhao Y Sethi P Li YY Mahta A Petrocca F Visone R Iorio M Roldo C Ferracin M Prueitt RL Yanaihara N Lanza G Scarpa A Vecchione A Negrini M Harris CC Croce CM Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation J Neurooncol 2010 98 297 304 10.1007/s11060-009-0077-0 19941032 · DOI
  17. Thery C Zitvogel L Amigorena S Exosomes: composition, biogenesis and function Nature Rev Immunol 2002 2 569 579 12154376
  18. Février B Raposo G Exosome: endosomal-derived vesicles shipping extracellular messages Curr Opin Cell Biol 2004 16 415 421 10.1016/j.ceb.2004.06.003 15261674 · DOI
  19. Pan BT Johnstone RM Fate of the transferrin receptor during maturation of sheep reticuloocytes in vitro: selective externalization of the receptor Cell 1983 33 967 978 10.1016/0092-8674(83)90040-5 6307529 · DOI
  20. Booth AM Fang Y Fallon JK Yang JM Hildreth JE Gould SJ Exosomes and HIV gag bud from endosome-like domains of the T cell plasma membrane J Cell Biol 2006 172 923 935 10.1083/jcb.200508014 16533950 PMC2063735 · DOI
  21. Valadi H Ekström K Bossios A Sjöstrand M Lee JJ Lötvall JO Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 2007 9 654 659 10.1038/ncb1596 17486113 · DOI · Paper page
  22. Pigati L Yaddanapudi SC Iyengar R Kim DJ Hearn SA Danforth D Hastings ML Duelli DM Selective release of microRNA species from normal and malignant mammary epithelial cells PLoS One 2010 5 e13515 10.1371/journal.pone.0013515 20976003 PMC2958125 · DOI
  23. Skog J Würdinger T Van Rijn S Meijer DH Gainche L Sena-Esteves M Curry WT Jr Carter BS Krichevsky AM Breakefield XO Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nat Cell Biool 2008 10 1470 1476 10.1038/ncb1800 PMC3423894 19011622 · DOI · Paper page
  24. Turchinovich A Weiz L Langheinz A Burwinkel B Characterization of extracellular circulating microRNA Nucleic Acids Res 2011 39 7223 7233 10.1093/nar/gkr254 21609964 PMC3167594 · DOI · Paper page
  25. Arroyo JD Chevillet JR Kroh EM Ruf IK Pritchard CC Gibson DF Mitchell PS Bennett CF Pogosova-Agadjanyan EL Stirewalt DL Tait JF Tewari M Argonaute 2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma Proc Natl Acad Sci USA 2011 108 5003 5008 10.1073/pnas.1019055108 21383194 PMC3064324 · DOI · Paper page

Cited by

Sorted by citations

Authors
Wang, Q., Li, P., Li, A., Jiang, W., Wang, H., Wang, J., & Xie, K.
Affiliations
  • Tianjin Huanhu Hospital (CN)
  • Tianjin Medical University (CN)
  • Tianjin Medical University General Hospital (CN)
Corresponding author
  • Wang, Jinhuan
  • Xie, Keliang
Venue
Journal of Experimental & Clinical Cancer Research
Published
2012-11-22
Volume
31
Issue
1
Pages
97-97
ISSN
  • 0392-9078 (ISSN-L)
  • 1756-9966
OpenAlex
W2099467660
Cited by
202
References
2
Citations by year
2026: 6 · 2025: 10 · 2024: 24 · 2023: 11 · 2022: 15 · 2021: 13 · 2020: 19 · 2019: 14 · 2018: 10 · 2017: 17 · 2016: 12 · 2015: 21 · 2014: 19 · 2013: 11
FWCI
5.42
Type
journal article
Language
en
Open access
Locations
  • Journal of Experimental & Clinical Cancer Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Natural Science Foundation of China (81101409, 2011KZ108)
  • Ministry of Health of the People's Republic of China
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords
glioblastoma, glioma, plasma microRNA, diagnostic biomarkers, prognostic factors, miR-21, miR-128, miR-342-3p, histopathological grade, treatment response, brain tumors
MeSH terms
Adult, Aged, Brain Neoplasms, Female, Glioblastoma, Humans, Male, Middle Aged, Prognosis, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Case-Control Studies, MicroRNAs, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review